We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Modifying Intestinal Flora Before Surgery Reduces Postoperative Complications in Colorectal Cancer Patients

By HospiMedica International staff writers
Posted on 06 Feb 2023
Image: Gut microbiota helps healing in colorectal cancer surgery (Photo courtesy of CRCHUM)
Image: Gut microbiota helps healing in colorectal cancer surgery (Photo courtesy of CRCHUM)

Up to 30% of all patients undergoing colorectal surgery suffer from serious complications due to poor healing of their intestinal barrier. Anastomotic complications cause inflammation, serious infection and cancer recurrence. Researchers have known that certain bacteria aid the development of colorectal cancer by producing toxins which damage colon cells or by promoting accumulation of DNA mutations or intestinal inflammation. A team of scientists has now identified two bacterial strains that directly affect whether or not anastomotic leakage, more commonly known as intestinal leakage, occurs.

To identify these two bacterial strains and facilitate modeling on large volumes of data, scientists at the CHUM Research Centre (CRCHUM, Montreal, Canada) developed the Biorepository for Inflammatory and Neoplastic Diseases of the Digestive Tract. The research biobank contains stool specimens of patients admitted for colorectal cancer who have provided their consent to be used for research purposes.

In a promising study, the researchers demonstrated for the first time in mice that modifying intestinal flora before surgery can reduce postoperative complications in colorectal cancer patients. Modifying the patients’ intestinal flora a few days prior to surgery by using a mix of prebiotics and probiotics could form the basis of a new therapeutic approach, according to the researchers. If such a treatment is continued for several days after the surgery, it could hasten the patients’ return to a healthy intestinal microbiota, reduce their hospital stay, improved their chances of survival and better their quality of life. The researchers are now carrying out additional studies to identify other bacteria associated with intestinal leakage or healing.

“In our study, we show that two bacterial strains detected in the stools of patients with this type of cancer have opposite effects on intestinal healing and therefore on recovery,” said principal author Manuela Santos, a professor at Université de Montréal. “Alistipes onderdonkii kh 33, mostly pro-inflammatory, increases the risk of leakage, while the anti-inflammatory effect of Parabacteroides goldsteinii kh 35 fosters healing.”

“The analysis of patients’ intestinal microbiota showed us that bacterial composition differed depending on the occurrence or not of intestinal leakage,” explained Roy Hajjar, a resident physician and the study’s first author. “Once we transplanted these different microbiota profiles to mice, we found that their risks of postoperative complications varied greatly. Simply put, the composition of the microbiota had a direct impact on their chances of recovery.”

Related Links:
CRCHUM

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Head Rest
Medifa 61114_3

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more